Vital KSK Holdings (TSE:3151) ROCE %: 7.08% (As of Mar. 2026)


TSE:3151 Vital KSK Holdings Inc TSE:3151
68 GF Score
Price 円1,520.00
GF Value 円1,322.65
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vital KSK Holdings ROCE %?

Vital KSK Holdings TSE:3151 -0.85% 68 ROCE % is 7.08% as of Mar. 2026. GuruFocus rates TSE:3151 with a GF Score™ of 68/100 and a GF Value™ of 円1,322.65 (Modestly Overvalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vital KSK Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was 7.08%.


Vital KSK Holdings  (TSE:3151) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Vital KSK Holdings ROCE % Related Terms


Vital KSK Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Vital KSK Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vital KSK Holdings ROCE % Chart

Vital KSK Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.05 6.79 7.24 8.67 8.84

Vital KSK Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.42 4.29 20.20 5.27 7.08
TSE:3151
68GF Score
Vital KSK Holdings Inc TSE:3151
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vital KSK Holdings ROCE % Calculation

Vital KSK Holdings's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=11570/( ( (299426 - 174880) + (320568 - 183219) )/ 2 )
=11570/( (124546+137349)/ 2 )
=11570/130947.5
=8.84 %

Vital KSK Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=9380/( ( (344402 - 216802) + (320568 - 183219) )/ 2 )
=9380/( ( 127600 + 137349 )/ 2 )
=9380/132474.5
=7.08 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.08% mean?
Vital KSK Holdings (TSE:3151) has a ROCE % of 7.08% as of Mar. 2026.
Is Vital KSK Holdings' ROCE % too high?
Vital KSK Holdings' current ROCE % is 7.08%. The Medical Distribution industry median ROCE % is 9.22. Vital KSK Holdings' value of 7.08% is 23.2% below this industry median. Overall, Vital KSK Holdings has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' ROCE % compare to MCK and COR?
Vital KSK Holdings' ROCE % of 7.08% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.22. Vital KSK Holdings' value of 7.08% is 23.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.22, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital KSK Holdings's current ROCE % of 7.08% is 23.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital KSK Holdings's current ROCE % is 7.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,322.65, compared to a current price of 円1,520.00 — trading 14.9% above its estimated fair value. The current ROCE % is 7.08% and 23.2% below the Medical Distribution industry median of 9.22. Vital KSK Holdings' overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current ROCE % is 7.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?

Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued. The current stock price of 円1,520.00 is trading 14.9% above its estimated GF Value™ of 円1,322.65. GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.

Key valuation signals for TSE:3151:

  • ROCE %: 7.08%
  • GF Value™: 円1,322.65 vs. price of 円1,520.00 (14.9% above fair value)
  • GF Score™: 68/100 with 6 warning signs
  • Industry Position: 23.2% below the Medical Distribution median

No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vital KSK Holdings Business Description

Address 1-1-12 Tsurumaki, Setagaya-ku, JPN, 154-0016
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
68GF Score

Get the complete analysis for TSE:3151

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,520.00
Price
円1,322.65
GF Value